SARTORIUS AG · ISIN: DE0007165607 · EQS - Company News

After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret

  Göttingen, July 2, 2024 Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be seeking another extension of his current contract when it expires in November 2025. The Supervisory Board has taken note of Kreuzburg's decision with g...

XETR:SRT Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News SARTORIUS AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (1)
Short Selling (DE) (5)
Short Selling (UK) (0)
02 July 2024 10:53AM
After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
DE0007165607
  Göttingen, July 2, 2024 Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be s...
SARTORIUS AG
About the publication
02 July 2024 10:47AM
After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
DE0007165607
Disclosure of inside information according to Article 17 MAR Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that, after more than 20 years as CEO, he will not be seeking another contr...
SARTORIUS AG
About the publication
16 May 2024 09:54AM
Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
DE0007165607
Göttingen, Germany, May 16, 2024 Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA   Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, and predictive design of manufacturing processe...
SARTORIUS AG
About the publication
13 May 2024 03:00PM
Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
DE0007165607
 Göttingen, Germany | May 13, 2024 Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification   Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing (ICB) platform Modular platform will combine highest flexibility with stand...
SARTORIUS AG
About the publication
18 April 2024 07:00AM
First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
DE0007165607
  Göttingen, April 18, 2024 Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed   Inventory reduction at customers further advanced; order intake increases by almost 10 percent in constant currencies Sales revenue down by 7.6 ...
SARTORIUS AG
About the publication
28 March 2024 03:28PM
Resolutions of the Annual General Meeting of Sartorius AG
DE0007165607
Göttingen, March 28, 2024 Resolutions of the Annual General Meeting of Sartorius AG At today’s virtual Annual General Meeting, the shareholders of Sartorius AG approved the proposals of the Executive Board and the Supervisory Board by a large majority, including the proposal to distribute a dividend of 0.74 euros per preference share and 0.73 euro...
SARTORIUS AG
About the publication
16 February 2024 10:00AM
Sartorius releases Annual Report for 2023
DE0007165607
Göttingen, February 16, 2024  Sartorius releases Annual Report for 2023 The life science group Sartorius has released its Annual Report for 2023 today. The document is available under the following link: https://ir-reports.sartorius.com/en/ag/fy-2023. Financial calendar  March 28, 2024     Annual General Meeting April 18, 2024       Publication of ...
SARTORIUS AG
About the publication
09 February 2024 03:45PM
The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
DE0007165607
Göttingen, February 9, 2024 The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 28, 2024, to pay a dividend of 0.74 euros per ...
SARTORIUS AG
About the publication
07 February 2024 12:39AM
Sartorius successfully completes placement of 200 million euros of treasury preference shares
DE0007165607
Disclosure of an inside information according to Article 17 of the Regulation (EU) No 596/2014 (MAR) Not to be released, published, distributed or circulated in South Africa, Canada, Australia, Japan or any other jurisdiction in which it would be unlawful to do so. This notification is not a prospectus within the meaning of Regulation (EU) 2017/11...
SARTORIUS AG
About the publication
06 February 2024 06:13PM
Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuilding
DE0007165607
Disclosure of an inside information according to Article 17 of the Regulation (EU) No 596/2014 (MAR) Not to be released, published, distributed or circulated in South Africa, Canada, Australia, Japan or any other jurisdiction in which it would be unlawful to do so. This notification is not a prospectus within the meaning of Regulation (EU) 2017/11...
SARTORIUS AG
About the publication
26 January 2024 07:00AM
Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028
DE0007165607
Göttingen, January 26, 2024 Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028   Preliminary 2023 results in line with forecast: sales revenue in constant currencies down 16.6 percent; underlying EBITDA margin of 28.3 percent Demand recovery in both divisions in the fourth quarter: ord...
SARTORIUS AG
About the publication
19 October 2023 07:00AM
Normalization of demand continues after end of pandemic
DE0007165607
Göttingen, October 19, 2023 Sartorius nine-month figures: Normalization of demand continues after end of pandemic   Sales revenue in constant currencies down 16.4 percent, excluding Covid-19-related business down slightly above 10 percent; underlying EBITDA margin at 28.8 percent Post-pandemic inventory reductions by customers taking longer than...
SARTORIUS AG
About the publication
12 October 2023 09:05PM
Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023
DE0007165607
Disclosure of inside information according to Article 17 MAR Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023 According to preliminary figures, the life science group Sartorius recorded consolidated sales revenue of around 2,546 million euros in the first nine months of 2023, which corresponds to a decline of around...
SARTORIUS AG
About the publication
12 October 2023 09:05PM
Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023
DE0007165607
Disclosure of inside information according to Article 17 MAR Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023 According to preliminary figures, the life science group Sartorius recorded consolidated sales revenue of around 2,546 million euros in the first nine months of 2023, which corresponds to a decline of around...
SARTORIUS AG
About the publication
12 October 2023 09:03PM
Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023
DE0007165607
Disclosure of inside information according to Article 17 MAR Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023 According to preliminary figures, the life science group Sartorius recorded consolidated sales revenue of around 2,546 million euros in the first nine months of 2023, which corresponds to a decline of aroun...
SARTORIUS AG
About the publication
12 October 2023 09:03PM
Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023
DE0007165607
Disclosure of inside information according to Article 17 MAR Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023 According to preliminary figures, the life science group Sartorius recorded consolidated sales revenue of around 2,546 million euros in the first nine months of 2023, which corresponds to a decline of aroun...
SARTORIUS AG
About the publication
12 October 2023 03:00PM
Sartorius commits to climate neutrality by 2045 
DE0007165607
Göttingen, Germany, October 12, 2023   Sartorius commits to climate neutrality by 2045 Long-term climate target complements existing climate strategy   Decarbonization to be carried out jointly with suppliers and customers  Transition to 100% electricity from renewable sources planned by 2030  Sartorius commits to extending its m...
SARTORIUS AG
About the publication
07 September 2023 06:00PM
Sartorius completes placement of bonds with a volume of 3 billion euros
DE0007165607
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, OR TO OR FOR THE BENEFIT OF U.S. PERSONS OR INTO ANY OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO.   Göttingen, September 7, 2023 Sartorius completes placement of bonds with a volume of 3 billion euros   Issue of four tranches with maturitie...
SARTORIUS AG
About the publication
29 August 2023 12:02PM
S&P Global Ratings assigns investment grade rating to Sartorius
DE0007165607
Göttingen, Germany, August 29, 2023 S&P Global Ratings assigns investment grade rating to Sartorius   Initial rating for Sartorius: Long-term BBB issuer rating with stable outlook S&P Global Ratings highlights Sartorius’ operational strength, financial discipline, and healthy end markets In its first credit rating, the life science gro...
SARTORIUS AG
About the publication
03 August 2023 07:09PM
Florian Funck appointed CFO of Sartorius
DE0007165607
Göttingen, August 3, 2023 Florian Funck appointed CFO of Sartorius New CFO to take over as of April 2024 At today’s meeting, the Supervisory Board of Sartorius AG appointed Dr. Florian Funck as Chief Financial Officer (CFO) and member of the Sartorius Executive Board, effective April 1, 2024. He succeeds Rainer Lehmann, with whom it was agreed in...
SARTORIUS AG
About the publication
21 July 2023 07:00AM
Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023
DE0007165607
Göttingen, July 21, 2023 Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023   Figures for the first half of 2023: Sales revenue -15.4 percent in constant currencies, high single-digit decline excluding Covid-19-related business; underlying EBITDA margin at 29.8 percent Sales revenue and profi...
SARTORIUS AG
About the publication
21 July 2023 07:00AM
SARTORIUS AG: Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023
DE0007165607
Göttingen, July 21, 2023 Sartorius maintains high profitability despite the expected temporary declines in the first half of 2023   Figures for the first half of 2023: Sales revenue -15.4 percent in constant currencies, high single-digit decline excluding Covid-19-related business; underlying EBITDA margin at 29.8 percent Sales revenue and profi...
SARTORIUS AG
About the publication
18 July 2023 01:15PM
SARTORIUS AG: Sartorius completes acquisition of Polyplus
DE0007165607
Göttingen, July 18, 2023 Sartorius completes acquisition of Polyplus The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of the French company Polyplus. The transaction was completed on July 18, 2023, after receiving the required regulatory approvals. Polyplus is a l...
SARTORIUS AG
About the publication
18 July 2023 01:15PM
Sartorius completes acquisition of Polyplus
DE0007165607
Göttingen, July 18, 2023 Sartorius completes acquisition of Polyplus The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of the French company Polyplus. The transaction was completed on July 18, 2023, after receiving the required regulatory approvals. Polyplus is a l...
SARTORIUS AG
About the publication
16 June 2023 10:29PM
Sartorius lowers forecast for 2023
DE0007165607
Disclosure of inside information according to Article 17 MAR   Sartorius lowers forecast for 2023   Based on continuing general weak demand dynamics, Sartorius expects sales revenue to develop below expectations in the second half of the year and thus adapts its guidance for both divisions as well as for the Group for fiscal 2023. The main facto...
SARTORIUS AG
About the publication
16 June 2023 10:29PM
Sartorius lowers forecast for 2023
DE0007165607
Disclosure of inside information according to Article 17 MAR   Sartorius lowers forecast for 2023   Based on continuing general weak demand dynamics, Sartorius expects sales revenue to develop below expectations in the second half of the year and thus adapts its guidance for both divisions as well as for the Group for fiscal 2023. The main facto...
SARTORIUS AG
About the publication
04 May 2023 07:30AM
SARTORIUS AG: Sartorius announces CFO transition
DE0007165607
Göttingen, May 4, 2023 Sartorius announces CFO transition   Rainer Lehmann to step down as Chief Financial Officer later this year; Sartorius commences search process Sartorius’ Chief Financial Officer Rainer Lehmann will step down from his position by the end of October 2023 to pursue a new opportunity outside the company. The Supervisory Board ...
SARTORIUS AG
About the publication
04 May 2023 07:30AM
Sartorius announces CFO transition
DE0007165607
Göttingen, May 4, 2023 Sartorius announces CFO transition   Rainer Lehmann to step down as Chief Financial Officer later this year; Sartorius commences search process Sartorius’ Chief Financial Officer Rainer Lehmann will step down from his position by the end of October 2023 to pursue a new opportunity outside the company. The Supervisory Board ...
SARTORIUS AG
About the publication
20 April 2023 07:00AM
SARTORIUS AG: First quarter of Sartorius characterized by normalization of demand; full-year outlook confirmed
DE0007165607
Göttingen, April 20, 2023 First quarter of Sartorius characterized by normalization of demand; full-year outlook confirmed   Figures for the first quarter of 2023 reflect expected temporary decline in sales revenue; - 13.2 percent in constant currencies, moderate decline excluding Covid-19-related business; underlying EBITDA margin at 30.1 percent...
SARTORIUS AG
About the publication
20 April 2023 07:00AM
First quarter of Sartorius characterized by normalization of demand; full-year outlook confirmed
DE0007165607
Göttingen, April 20, 2023 First quarter of Sartorius characterized by normalization of demand; full-year outlook confirmed   Figures for the first quarter of 2023 reflect expected temporary decline in sales revenue; - 13.2 percent in constant currencies, moderate decline excluding Covid-19-related business; underlying EBITDA margin at 30.1 percent...
SARTORIUS AG
About the publication
31 March 2023 08:50AM
Sartorius to acquire Polyplus
DE0007165607
Göttingen, March 31, 2023 Sartorius to acquire Polyplus France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros The life science group Sart...
SARTORIUS AG
About the publication
31 March 2023 08:50AM
SARTORIUS AG: Sartorius to acquire Polyplus
DE0007165607
Göttingen, March 31, 2023 Sartorius to acquire Polyplus France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros The life science group Sart...
SARTORIUS AG
About the publication
29 March 2023 07:50PM
Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
DE0007165607
Göttingen, March 29, 2023 Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division At today’s meeting, the Supervisory Board of Sartorius AG appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023. From June 16, 2023, Alexandra Gatzemeyer will succeed Gerr...
SARTORIUS AG
About the publication
29 March 2023 07:50PM
SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
DE0007165607
Göttingen, March 29, 2023 Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division At today’s meeting, the Supervisory Board of Sartorius AG appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023. From June 16, 2023, Alexandra Gatzemeyer will succeed Gerr...
SARTORIUS AG
About the publication
29 March 2023 05:04PM
Resolutions of the Annual General Meeting of Sartorius AG
DE0007165607
Göttingen, March 29, 2023 Resolutions of the Annual General Meeting of Sartorius AG At today’s virtual Annual General Meeting, the shareholders of Sartorius AG approved the proposals of the Executive Board and the Supervisory Board by a large majority, including the proposal to distribute a dividend of 1.44 euros per preference share and 1.43 euro...
SARTORIUS AG
About the publication
29 March 2023 05:04PM
SARTORIUS AG: Resolutions of the Annual General Meeting of Sartorius AG
DE0007165607
Göttingen, March 29, 2023 Resolutions of the Annual General Meeting of Sartorius AG At today’s virtual Annual General Meeting, the shareholders of Sartorius AG approved the proposals of the Executive Board and the Supervisory Board by a large majority, including the proposal to distribute a dividend of 1.44 euros per preference share and 1.43 euro...
SARTORIUS AG
About the publication
10 February 2023 11:19AM
SARTORIUS AG: The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share
DE0007165607
The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share Göttingen, February 10, 2023. The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 29, 2023, to pay a dividend of 1.44 euros per...
SARTORIUS AG
About the publication
10 February 2023 11:19AM
The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share
DE0007165607
The Supervisory Board of Sartorius AG proposes a dividend of 1.44 euros per preference share Göttingen, February 10, 2023. The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 29, 2023, to pay a dividend of 1.44 euros per...
SARTORIUS AG
About the publication
05 July 2021 06:53PM
SARTORIUS AG: Sartorius provides preliminary first-half financial key figures and raises forecast for 2021
DE0007165607
Disclosure of inside information according to Article 17 MAR Sartorius provides preliminary first-half financial key figures and raises forecast for 2021 Sartorius announces today that it expects strong first-half performance and raises its forecast for the full year of 2021. For the first six months ended June 30, the company expects revenue gro...
SARTORIUS AG
About the publication
More SARTORIUS AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 1 23rd July 2024 Kappich, Dr. Lothar Ewald DD
Short Seller (DE) 5 5th June 2024 AQR Capital Management, LLC SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN